Clinical Trials Logo

Filter by:
NCT ID: NCT06451575 Recruiting - Behçet Disease Clinical Trials

Thrombophilia and Thrombosis in Behçet's Disease

Start date: June 1, 2023
Phase:
Study type: Observational

Behçet's disease (BD) is a systemic vasculitis of unknown cause, affecting mainly young adults. Vasculopathy has been reported in 16.8-51.5% of cases. Genetic, infectious factors, environmental factors, presence of autoantibodies, endothelial pathologies and hypercoagulability are responsible for the etiopathogenesis of BD. The main involvements responsible for morbidity and mortality in Behçet's disease are ocular, major cardiovascular and neurological involvements. Although there is an increased thrombotic risk in the etiopathogenesis of Behçet's disease, the cellular and molecular mechanisms are not fully understood. Although endothelial dysfunction due to inflammation has been shown to be the primary cause of vascular damage in Behçet's disease, some clinical evidence suggests that hypercoagulable states also contribute to thrombosis. The most common form of vascular involvement in Behçet's disease is deep vein thrombosis in the lower extremities. Arterial occlusion mostly affects the subclavian and pulmonary arteries. Although arterial involvement is rarer than venous involvement in Behçet's disease, morbidity and mortality are higher than venous involvement. Although an increased thrombotic risk is mentioned in the etiopathogenesis of Behçet's disease, it is still controversial whether vasculitis or susceptibility to hypercoagulability plays a role in the pathogenesis of venous thrombosis. In addition, there are very few studies in the literature in which all thrombophilic parameters were analysed. Again, there is no recent study on this subject. The aim of our study is to determine the risk of hypercoagulability in Behçet's disease patients with vascular involvement, which has a highly mortal course.

NCT ID: NCT06451536 Recruiting - Clinical trials for Mesotheliomas Pleural

Ga-68 FAPI PET Before Immunotherapy

FAPBI
Start date: April 30, 2024
Phase: N/A
Study type: Interventional

It is aimed to evaluate FAP expression and its success in predicting treatment response before immunotherapy used in the treatment of malignant mesothelioma with Ga68 FAPI PET/CT imaging, which allows in vivo evaluation of FAP expression, which is thought to be associated with immunosuppression and resistance to immunotherapy.

NCT ID: NCT06449755 Recruiting - Metacarpal Fracture Clinical Trials

Elastic Nail Versus Screw for Intramedullary Fixation of Displaced Fractures of the Fifth Metacarpal Neck

Boxerfx
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare two different intramedullary fixation technique in patient diagnosed with deplased fifth metacarpal neck fracture. The main questions it aims to answer are: - Can percutaneous screw application be a more stable fixation method than intramedullary elastic nail application? - Can screw application create a significant difference in the recovery of grip strength in the early period compared to elastic nail application? Patients will be followed up at the 1st week, 1st month and 3rd month postoperatively. Functionality will be evaluated with Quick DASH score at the 3rd month. At the 1st and 3rd month controls, grip strength will be evaluated. At the same time, metacarpal shortening and angulations will be measured on x-ray. Researchers will compare percutaneous screw and elastic nail group to see grip strength, healing time and radiologic parameter difference.

NCT ID: NCT06449599 Recruiting - Postoperative Pain Clinical Trials

Rhomboid Intercostal Block in Cardioverter Defibrillator Implantation (ICD)

Start date: June 4, 2024
Phase: N/A
Study type: Interventional

ICD implantation can be painful procedure even under local anesthesia and sedation. In this prospective-randomised study, ultrasound-guided rhomboid intercostal block will be performed to reduce intraoperative and postoperative pain. Also comfort of patients and the cardiologists will be evaluated. In this way, we expect to reduce possible complications and make this procedure more comfortable for patients and clinicians.

NCT ID: NCT06449573 Recruiting - Asthma Clinical Trials

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

Start date: March 1, 2024
Phase:
Study type: Observational

The aim of the study compare the cardiopulmonary parameters of individuals with asthma with healthy subjects.

NCT ID: NCT06449456 Recruiting - Quality of Life Clinical Trials

Exercise Capacity, Physical Fitness, and Physical Activity Levels in Children With CAH

Start date: February 22, 2024
Phase:
Study type: Observational [Patient Registry]

Congenital Adrenal Hyperplesia (CAH) is a group of automosal recessive disorders that develop due to a deficiency of one of the five enyzmes necessary for cortisol synthesis in the adrenal cortex. Research indicates a predisposition in children and adolescents with CAH towards adverse metabolic changes such as obesity, hypertension, insulin resistance and increased intima-media thickness. This study aims to compare the extent to which children and adolescents with CAH are effected in terms of respiratory and peripheral muscle strength, exercise capasity, physical fitness and physical activity levels compared o their matched healthy individuals.

NCT ID: NCT06448377 Recruiting - Airway Management Clinical Trials

Initiation of Airway Code: The Role of the Airway Team in Unexpected Difficult Airways

Start date: March 15, 2024
Phase:
Study type: Observational

The aim of our study is to observationally examine our unexpected difficult airway incidence and intervention times. In addition, it is aimed to discuss the clinical effect of a team specialized in airway intervention intervening in cases by call on the success of airway intervention. In this discussion, it is aimed to use the opinion-opposition method.

NCT ID: NCT06447818 Recruiting - Clinical trials for Obstructive Sleep Apnea of Adult

Changes in Difficult Airway Markers After Surgery for Obstructive Sleep Apnoea Syndrome

Start date: May 15, 2024
Phase:
Study type: Observational [Patient Registry]

This study investigates the changes in difficult airway markers at 6 months post operatively in patients undergoing obstructive sleep apnoea surgery

NCT ID: NCT06447688 Recruiting - Radial Artery Spasm Clinical Trials

Does Verapamil Given Orally Prevent Radial Artery Spasm During Transradial Coronary Angiography

Start date: June 5, 2024
Phase: Phase 4
Study type: Interventional

Coronary angiography (CAG) is an invasive imaging method performed to determine the degree of coronary artery disease. Radial artery spasm (RAS) is one of the most common complications during coronary angiography performed via the transradial approach, causing patient discomfort or sometimes interrupting the procedure. There are many studies on RAS, and various pharmacoagents administered intravenously (intraarterial) to prevent RAS have been described. However, there is limited data in the literature regarding oral pharmacoagents that will prevent this complication. In our study, the preventive effect of Verapamil, given orally 2 hours before coronary angiography, on radial artery spasm will be investigated.

NCT ID: NCT06447142 Recruiting - Meniscus Tear Clinical Trials

The Open Kinetic Chain and Closed Kinetic Chain Strengthening Exercises in Degenerative Meniscus Tears

Start date: June 10, 2024
Phase: N/A
Study type: Interventional

This randomized-controlled trial aims to compare the effect of open kinetic chain and closed kinetic chain strengthening exercises on pain, function, and health-related quality of life in degenerative meniscus tears.